| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $291.3M | +9.1% |
| Cost of Revenue | $101.0M | +1.8% |
| Gross Profit | $190.2M | +13.4% |
| R&D Expense | $33.3M | +24.5% |
| SG&A Expense | $57.7M | +2.6% |
| Operating Income | $3.9M | +92.9% |
| Pre-tax Income | $17.8M | +69.2% |
| Income Tax | $5.3M | +224.5% |
| Net Income | $12.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $100.5M | +27.9% |
| Accounts Receivable | $424.8M | +13.1% |
| Current Assets | $575.5M | +2.4% |
| Total Assets | $739.5M | +6.4% |
| Current Liabilities | $418.8M | +10.3% |
| Total Liabilities | $462.3M | +15.8% |
| Stockholders' Equity | $277.3M | -6.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $73.4M | -9.5% |
| Capital Expenditures | $17.6M | +65.9% |
| Investing Cash Flow | $22.3M | +157.2% |
| Financing Cash Flow | -$73.5M | -31.3% |
| Free Cash Flow | $55.8M | -20.8% |
| +40.8% |
| EPS (Basic) | $0.25 | +47.1% |
| EPS (Diluted) | $0.23 | +43.8% |